{"organizations": [], "uuid": "ec1572393834940523e83b3a06fadb1b1587f001", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180413.html", "section_title": "Archive News &amp; Video for Friday, 13 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhejiang-conba-pharmaceuticals-con/brief-zhejiang-conba-pharmaceuticals-consortium-acquires-stake-in-jiangxi-chinese-medicine-firm-idUSH9N1RO03L", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhejiang Conba Pharmaceutical's Consortium Acquires Stake In Jiangxi Chinese Medicine Firm", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-13T17:56:00.000+03:00", "replies_count": 0, "uuid": "ec1572393834940523e83b3a06fadb1b1587f001"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhejiang-conba-pharmaceuticals-con/brief-zhejiang-conba-pharmaceuticals-consortium-acquires-stake-in-jiangxi-chinese-medicine-firm-idUSH9N1RO03L", "ord_in_thread": 0, "title": "BRIEF-Zhejiang Conba Pharmaceutical's Consortium Acquires Stake In Jiangxi Chinese Medicine Firm", "locations": [], "entities": {"persons": [], "locations": [{"name": "jiangxi", "sentiment": "none"}, {"name": "zhejiang conba", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}, {"name": "jiangxi", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-zhejiang conba pharmaceutical", "sentiment": "negative"}, {"name": "pharmaceutical co ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 13 (Reuters) - Zhejiang CONBA Pharmaceutical Co Ltd :\n* SAYS ITS CONSORTIUM ACQUIRES 41 PERCENT STAKE IN JIANGXI CHINESE MEDICINE FIRM FOR 300.35 MILLION YUAN ($47.84 million) Source text in Chinese: bit.ly/2v9X0Kh Further company coverage: ($1 = 6.2785 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://bit.ly/2v9X0Kh", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-13T17:56:00.000+03:00", "crawled": "2018-04-14T13:23:03.001+03:00", "highlightTitle": ""}